Options for the Control of Influenza VIII

Held every 3 years, Options for the Control of Influenza is the largest international scientific conference exclusively devoted to influenza. Options VIII will showcase recent advances in the basic science and control and prevention of influenza. Whatever your domain of expertise – virology, veterinary medicine, human medicine, public health policy, industry or journalism – Options for the Control of Influenza VIII is the premier conference bringing together experts dedicated to all aspects of influenza. Presentation formats will include keynote addresses, invited lectures, scientific workshops, abstract presentations, satellite meetings and poster sessions.

The 2013 conference will allow delegates to experience the beauty and warm hospitality of Cape Town, South Africa. Delegates at Options VIII will experience an unforgettable mix of modern and traditional African ambience. Options VIII will highlight these characteristics along with cultural events strategically placed within the agenda. In addition, delegates will be provided an opportunity to participate in many pre-conference or post-conference tours on their own to encounter nature and history and create memories to treasure.

Conference Goals and Objectives:

Provide comprehensive scientific guidance for all stakeholders involved in influenza prevention, control, and treatment, including seasonal pandemic planning
Promote genuine international and multidisciplinary collaboration, supporting the full spectrum of influenza research from basic science to the development of new vaccines and antiviral agents to epidemiology and control programs
Provide a collegial atmosphere where scientists working in public health and scientists working in agricultural or veterinary agencies may exchange information to develop collaborative approaches to the control and prevention of pandemic influenza
Maximize the opportunities for informal discussions and exchange of ideas between representatives of government agencies, academia, and industry

Join us in Cape Town and experience this premier event!
+ show speakers and program
Wednesday, 4 September 2013
07.00 – 18.00
Registration

Thursday, 5 September 2013
09.00 – 09.40
Opening Ceremony
(CTICC Hall 4A)

Welcome from Congress and isirv Chairs

Welcome from Cape Town Dignitary
Dr. Aaron Motsoaledi, Minister of Health, South Africa

09.40 – 11.00

Morning Plenary Session 1 – Virology
(CTICC Hall 4A)

vRNP structure and how does the polymerase work
Yoshihiro Kawaoka, University of Wisconsin Madison, School of Veterinary Medicine, Madison, Wisconsin, United States

PA-x and PB1-N40
Paul Digard, University of Cambridge, Cambridge, United Kingdom

Importins and their role in host restriction of avian influenza viruses
Gülsah Gabriel, Heinrich-Pette-Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany

11.00 – 11.30

Morning Networking and Refreshment

11.30 – 13.00

Midday Plenary Session 2 – Pathogenesis

Lung injury / ARDS
Malik Peiris, Centre of Influenza Research, School of Public Health, The University of Hong Kong, Hong Kong SAR, China

Overview on pathogenesis and transmission of swine influenza
Juergan Richt, Kansas State University, College of Veterinary Medicine, Manhattan, Kansas, United States

Experimental studies of influenza virus transmission in humans
Jonathan Van-Tam, Health Protection & Influenza Research Group, Epidemiology and Public Health, University of Nottingham, Nottingham, United Kingdom

13.00 – 14.00

Lunch
(CTICC Hall 4A)

14.00 – 15.30

Concurrent Afternoon Workshops – A

Workshop A1
(CTICC Meeting room 2.41-level two)

Workshop A2
(CTICC Meeting room 2.61-level two)

Workshop A3
(CTICC Hall 4A)

15.30 – 16.00

Afternoon Networking and Refreshment

16.00 – 17.30

Concurrent Evening Workshops - B
Workshop B1
(CTICC Meeting room 2.41-level two)

Workshop B2
(CTICC Meeting room 2.61-level two)

Workshop B3
(CTICC Hall 4A)

17.30 – 19.30

Welcome Reception
(Options VIII Exhibit Hall)

Friday 6, September 2013

09.00 – 09.40

Cross-Cutting Keynote
(CTICC Hall 4A)

The Interaction between Influenza and lung co-pathogens
Keith Klugman, Department of Global Health at the Rollins School of Public Health at Emory University, Atlanta, GA, United States

09.40 – 11.00

Morning Plenary Session 1 – Epidemiology
(CTICC Hall 4A)

Maternal influenza immunization
Rob Breiman, Emory University, Atlanta, GA, United States

Epidemiology of influenza in Africa
Cheryl Cohen, NICD, Cape Town, South Africa

Challenges to estimating influenza mortality/severity
Anthony Mounts, Global Influenza Programme, Health Security & Environment Cluster, World Health Organization, Geneva, Switzerland

11.00 – 11.30

Morning networking and Refreshment

11.30 – 13.00

Midday Plenary Session 2 – Immunology
(CTICC Hall 4A)

Mx (structure, susceptibility) and the interferon response
Otto Haller, University of Hospital Freiburg, Freiburg, Germany

T cells in the respiratory tract
Thomas Braciale, University of Virginia, Charlottesville, Virginia, United States

Detection of cross-reactive B cells and applications for therapeutics
Patrick Wilson, The University of Chicago, Chicago, Illinois, United States

13.00 – 14.00

Lunch
(CTICC Hall 2/3)

14.00 – 15.30

Concurrent Afternoon Workshops - C

Workshop C1
(CTICC Meeting room 2.41-level two)

Workshop C2
(CTICC Meeting room 2.61-level two)

Workshop C3
(CTICC Hall 4A)

15.30 – 16.00

Afternoon Networking and Refreshment

16.00 – 17.30

Concurrent Evening Workshops - D
Workshop D1
(CTICC Meeting room 2.41-level two)

Workshop D2
(CTICC Meeting room 2.11-level two)

Workshop D3
(CTICC Hall 4A)

17.30 – 21.00

Poster Reception
Walkabout session
(Options VIII exhibition hall)

Saturday 7 September 2013
Back to top ↑
09.00 – 11.10

Feature Cornerstone Session: Animal-Human Interface
(CTICC Hall 4A)

Mammalian adaptation of influenza viruses: what we know and what we don't
Terrence Tumpey, Immunology and Pathogenesis Branch, Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States

Risk assessing animal viruses for pandemic threat
Nancy Cox, WHO Collaborating Center for Surveillance Epidemiology and Control of Influenza, National Center for Immunization and Respiratory Diseases, Coordinating Center for Infectious Disease, Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States

Human H5N1 disease
Menno de Jong, Department of Medical Microbiology, University of Amsterdam, Amsterdam, The Netherlands

Ecology, evolution, and human health risks from emerging swine influenza viruses
Richard Webby, Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Eithics and Politics of Influenza: DURC, PIP, and Impact on Publishing
Panelists include:

Yoshihiro Kawaoka, University of Wisconsin Madison School of Veterinary Medicine, Madison, Wisconsin, United States
Charles Russell, St Jude Children's Research Hospital, Memphis, Tennesee, United States
Additional panelists: TBD
11.10 – 11.30

Scholarship Awards Ceremony
(CTICC Hall 4A)

11.30 – 12.30

isirv Annual General Meeting
(CTICC Hall 4A)

12.30 – 19.00

Cultural Event - (subject to funding; if no funding is available delegates will be on their own to explore the city)

Sunday 8 September 2013
Back to top ↑
09.00 – 09.40

Cross-Cutting Keynote
(CTICC Hall 2/3)

Universal epitopes, their application to vaccines and therapy, and importance in influenza epidemiology
Speaker: TBD

09.40 – 11.00

Morning Plenary Session 1 – Diagnostics
(CTICC Hall 4A)

Real-time PCR
Stephen Lindstrom, National Center for Immunization for Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States

Influenza whole genome analysis and its role in diagnostics, patient care, and public health
Monica Galiano, Health Protection Agency, London, United Kingdom

Clinical relevance of influenza viral load measurement
Nelson Lee, Prince of Wales Hospital, Wales, United Kingdom

11.00 – 11.30

Morning Networking and Refreshment

11.30 – 13.00

Midday Plenary Session 2 – Clinical
(CTICC Hall 4A)

Clinical research in an emergent epidemic setting
Jeremy Farrar, Oxford University Clinical Research Unit, Viet Nam, Ho Chi Minh City, Vietnam

Influenza and pregnancy
Shigeru Saito, Department of Obstetrics and Gynecology, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, Toyama Prefecture, Japan

The many faces of influenza
Tim Uyeki, Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States

13.00 – 14.00

Lunch
(CTICC Hall 2/3)

14.00 – 15.30

Concurrent Afternoon Workshops - E

Workshop E1
(CTICC Meeting room 2.41-level two)

Workshop E2
(CTICC Meeting room 2.61-level two)

Workshop E3
(CTICC Hall 4A)

15.30 – 16.00

Afternoon Networking and Refreshment

16.00 – 17.30

Concurrent Evening Workshops - F
Workshop F1
(CTICC Meeting room 2.41-level two)

Workshop F2
(CTICC Meeting room 2.41-level two)

Workshop F3
(CTICC Hall 4A)

17.30 – 21.00

Poster Study Hall
Walkabout session #2
(Options VIII Exhibition Hall)

Monday 9 September 2013
Back to top ↑
09.00 – 09.40

Cross Cutting Keynote
(CTICC Hall 4A)

Host genetics of human influenza
Paul Kellam, Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom

09.40 – 11.00

Morning Plenary Session 1: Therapeutic Interventions
(CTICC Hall 4A)

Overview of existing therapies/clinical experience with neuraminidase inhibitors, including resistance and antiviral combinations
Michael Ison, Northwestern University, Evanston, Illinois, United States

Overview of the role of immunmodulation, cellular factors, and proteases
Béatrice Riteau, Faculte de Medicine de Laennec, Unité VirPathFrance, Lyon, France

Polymerase inhibitors
Martin Schwemmle, University Hospital Freiburg, Freiburg, Germany

11.00 – 11.30

Morning Networking and Refreshment

11.30 – 13.00

Midday Plenary Session 2: Vaccines
(CTICC Hall 4A)

Overview of vaccine effectiveness issues and controversies
Alain Moren, EpiConcept, Paris, France

Next generation of influenza vaccines
Rick Bright, HHS/OS/ASPRA BARDA, Washington, District of Columbia, United States

Clinical aspects in the development and licensing of the Russian-based live attenuated influenza vaccines for pandemic influenza preparedness in developing countries
Larisa Rudenko, Institute of Experimental Medicine of the NorthWest Branch of the Russian Academy of Medical Sciences, St. Petersburg, Russia

13.00 – 14.00

Lunch

14.00 – 15.30

Concurrent Morning Workshops - G

Workshop G1
(CTICC Meeting room 2.41-level two)

Workshop G2
(CTICC Meeting room 2.61-level two)

Workshop G3
(CTICC Hall 4A)

15.30 – 16.00

Afternoon Networking and Refreshment

16.00 – 17.30

Closing Plenary Session – Public Health
(CTICC Hall 4A)

Usefulness of modeling for decision making on influenza
Speaker: TBD

Non-pharmaceutical interventions-effectiveness and consequences
Benjamin Cowling, University of Hong Kong, Hong Kong SAR, China

Update on global vaccine policy
Marie-Paule Kieny, World Health Organization, Geneva, Switzerland

5 Sep - 10 Sep 2013
Cape Town
South Africa
meeting website